David Lechuga-Ballesteros is an experienced pharmaceutical product developer with a diverse career in scientific research and leadership. They earned a Ph.D. from the University of Michigan and a Bachelor's degree from Universidad Nacional Autónoma de México. David's professional journey includes roles as a Scientist at Parke-Davis Pharmaceutical Research and Abbott Laboratories, and they held positions as a Research Fellow at Nektar Therapeutics and Senior Director of R&D at Aridis Pharmaceuticals. Currently, they serve as the Head of Innovation for AstraZeneca's Inhalation Product Development while also being a Principal Scientist at Pearl Therapeutics. Previously, they were the Executive Scientific Director at AstraZeneca from 2017 to 2022.
This person is not in any teams
This person is not in any offices